We’ve been working on something exciting in the background, and are proud to finally start to introduce Accelagen’s new look with you.
https://t.co/04kzkuxzEK
I’m supporting @AusBiotech's #AusBio21 conference online and on-demand from 25 - 29
October - will you be attending? Register today & I look forward to seeing you online
https://t.co/GkAfYNiIIP
More exciting news from the Accelagen team! We are excited to partner with RemeGen to progress the development of their novel antibody-drug conjugate in Australia.
Read about it here https://t.co/2sAYWoFewh
Accelagen are proud of a collaboration that provide new treatment options for Australian patients, particularly for those who suffer from rare diseases.
Read more here: https://t.co/LSxaofRXuU
#regulatoryaffairs#regulatoryapproval#strategicpathtomarket
Unfortunately with #viclockdown, the team can't attend @ARCSAustralia Conference. However our Regulatory Manager Sarah Henderson will be there - meet up with her to discuss how the Accelagen team can drive your objectives!
#regulatoryaffairs#ARCS2021#strategicpathtomarket
Check out the Accelagen profile on the Victorian Clinical Trials gateway here: https://t.co/NoBpJtVuoR. Although our head office is in Victoria, our team are based around Australia, ensuring we can remain active during #VicLockdown#clinicaltrials#regulatoryaffairs
Great to be featured in the BioMelbourne Network newsletter!
Get in touch and discover more about the team and what we do to make a difference!
https://t.co/TkXMsrPShB
$RHY continues to position itself as a global leader in colorectal cancer diagnosis, through the development of ColoSTAT®.
Half-Year report highlights:
↗️ Core Technology
↗️ Global Capability
↗️ Commercialisation
#bowelcancer#cancer
Link to report: https://t.co/pw6M7FzvLN
The TGA has granted provisional approval to Pfizer Australia Pty Ltd for its COVID-19 vaccine, COMIRNATY, making it the first COVID-19 vaccine to receive regulatory approval in Australia.
Read more: https://t.co/xgtY5Ws4Iw
@UnitedEnergyAU we have had power out in Blackburn since a just after 5am and still no sign of it returning soon. Please update your outage website to keep your customers aware, including a possible restoration time!
Today we launched the Early Scientific Advice service, a new initiative enabling applicants to request scientific advice on specific data before they apply to register a medicine. To access the Early Scientific Advice service or find out more visit: https://t.co/Eauhpx9AS5
The @TGAgovau have introduced Early Scientific Advice program to allow Sponsors to discuss specific data and gain Agency feedback prior submitting application for product registration. A great initiative!
#regulatoryaffairs#scientificadvice https://t.co/eSATXVQDz5
No one knows what the effectiveness of a Covid vaccine will be—we don’t have the studies yet. But even very good vaccines don’t take most diseases off the table. It’s going to take a comprehensive response, working together, to get past this.
It has been a busy time for our regulatory team, with the submission of four Cat 1’s to the TGA and an IND Amendment this week. Our regulatory publishing activities have certainly gone up a gear.
#ectd#regulatoryaffairs#lorenz#newproducts